AJP - Renal AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 296: F317-F327, 2009. First published November 26, 2008; doi:10.1152/ajprenal.90450.2008
0363-6127/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/2/F317    most recent
90450.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakayama, T.
Right arrow Articles by Nakagawa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakayama, T.
Right arrow Articles by Nakagawa, T.

Endothelial injury due to eNOS deficiency accelerates the progression of chronic renal disease in the mouse

Takahiro Nakayama,1,3 Waichi Sato,1 Tomoki Kosugi,1 Li Zhang,2 Martha Campbell-Thompson,2 Ashio Yoshimura,3 Byron P. Croker,2 Richard J. Johnson,1,4 and Takahiko Nakagawa1,4

1Division of Nephrology; 2Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida; 3Division of Nephrology, Showa University Fujigaoka Hospital, Kanagawa, Japan; and 4Division of Renal Disease and Hypertension, University of Colorado Denver, Aurora, Colorado

Submitted 3 August 2008 ; accepted in final form 21 November 2008

The vascular endothelium expresses endothelial nitric oxide synthase (eNOS) that generates nitric oxide (NO) to help maintain vascular integrity due to its anti-inflammatory, antiproliferative, and antithrombogenic effects. Pharmacological blockade of NO production has been shown to exacerbate renal injury in chronic renal disease and induces endothelial cell loss. However, pharmacological inhibition of NO nonspecifically blocks other types of NOS and therefore does not define the specific role of eNOS in kidney disease. We hypothesized that a lack of endothelial eNOS can induce a loss of glomerular and peritubular capillary endothelium and exacerbate renal injury in progressive renal disease. We tested out this hypothesis using remnant kidney (RK) in eNOS knockout (eNOS KO) mice. Systolic blood pressure was significantly higher, and renal function was worse in RK-eNOS KO mice compared with those in RK-C57BL6 mice. eNOS deficiency resulted in more severe glomerulosclerosis, mesangiolysis, and tubular damage. Glomerular and tubular macrophage infiltration and collagen deposition were also greater in RK-eNOS KO mice. Renal injuries in the RK-eNOS KO mice were accompanied by a greater loss of endothelial cells that was shown to be due to both a decrease in endothelial cell proliferation and an increase in apoptosis. A lack of eNOS accelerates both glomerular and tubulointerstitial injury with a loss of glomerular capillaries and peritubular capillaries. Impaired endothelial function is likely a direct risk factor for renal disease.

endothelial nitric oxide synthase; glomerular endothelial cell; mesangiolysis



Address for reprint requests and other correspondence: T. Nakagawa, Division of Renal disease and Hypertension, Univ. of Colorado Denver, P.O. Box C281, Aurora, CO 80045 (e-mail: takahiko.nakagawa{at}uchsc.edu or takahiko.nakagawa{at}UCdenver.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.